Accueil   Diary - News   All news Novasep opens €27m new Viral Vector Commercial Production Facility

Novasep opens €27m new Viral Vector Commercial Production Facility

 

 

 

Lyon, France, October 2nd, 2018 – Novasep, a leading supplier of services and technologies for the life sciences industry, has opened a new 27 M€ viral vector production facility in Seneffe, Belgium. The production of the first cGMP batches will start in H1 2019.

 

This project, known as Senrise-IV, represents an operational and strategic step forward for Novasep. This facility features the bioproduction of viral vectors at commercial industrial scale in an integrated manner and with full control of the value creation chain. To this end, Novasep has doubled its on-site workforce with the creation of 75 positions

 

 

Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree